Equity Details
Price & Market Data
Price: $19.71
Daily Change: +$0.705 / 3.58%
Daily Range: $18.81 - $20.10
Market Cap: $34,921,180
Daily Volume: 5,286
Performance Metrics
1 Week: -1.48%
1 Month: 6.46%
3 Months: 16.87%
6 Months: 139.1%
1 Year: 363.7%
YTD: 28.12%
About Palatin Technologies, Inc. (PTN)
Comprehensive analysis of Palatin Technologies, Inc. (PTN). Currently at 19.71, with a daily change of +$0.705 / 3.58%. Market cap: 34,921,180. Evaluate its performance over YTD, 1-month, and 6-month periods.
Company Details
Employees: 29
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.